US FDA grants EUA for Cepheid Xpert Mpox test for use in a point-of-care setting
The US Food and Drug Administration (FDA) granted an emergency use authorization (EUA) for the Cepheid Xpert Mpox test for use in a point-of-care setting.
Validation data was gathered through the National Institutes of Health (NIH) Independent Test Assessment Programme established as a collaboration between the FDA and the NIH.
The Xpert Mpox test is a real-time polymerase chain reaction (PCR) assay to detect Mpox virus DNA in lesion swab specimens from individuals suspected of having monkeypox by their healthcare provider.
The EUA is the latest example of the FDA
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!